Noninvasive Detection of Melanoma Using Genetic Information
Author Information
Author(s): Wachsman W, Morhenn V, Palmer T, Walls L, Hata T, Zalla J, Scheinberg R, Sofen H, Mraz S, Gross K, Rabinovitz H, Polsky D, Chang S
Primary Institution: DermTech International, Inc.
Hypothesis
Can epidermal genetic information retrieval (EGIR) be used to distinguish melanomas from naevi?
Conclusion
The study demonstrates that EGIR can accurately detect melanoma using a 17-gene genomic biomarker.
Supporting Evidence
- 312 genes were found to be differentially expressed between melanomas, naevi, and normal skin.
- The 17-gene classifier achieved 100% sensitivity and 88% specificity in detecting melanoma.
- EGIR technology allows for noninvasive sampling of RNA from the skin.
- The classifier was validated with an independent test dataset.
- Histopathological review confirmed one false-positive naevus actually contained melanoma.
Takeaway
Scientists found a way to tell if a skin spot is cancerous by looking at tiny bits of genetic material from the skin without needing to do a painful biopsy.
Methodology
The study used epidermal genetic information retrieval (EGIR) to collect RNA from skin samples, which was then analyzed for gene expression differences.
Potential Biases
Potential bias in histopathological readings and the subjective nature of visual assessments.
Limitations
The study may have false positives due to misclassification of naevi as melanomas.
Participant Demographics
{"melanoma":{"n":76,"mean_age":60.5,"gender_ratio":"27 females, 49 males"},"naevus":{"n":126,"mean_age":45.3,"gender_ratio":"58 females, 68 males"}}
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website